ImmuCell Corp (ICCC)

5.05 0.00 (0.00%) USD  |  NASDAQ  |  Apr 17, 16:00
More

ImmuCell Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ICCC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2020. Upgrade now.
Date Value
October 06, 2020 --
August 14, 2020 --
Date Value
July 13, 2020 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Aug 14 2020
Upgrade
Maximum
Jul 13 2020
Upgrade
Average
Upgrade
Median
Aug 14 2020

Revenue Estimates for Current Fiscal Year Benchmarks

NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade
Ampio Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade